Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death. Circulation. 1998;98(10):946–52. https://doi.org/10.1161/01.cir.98.10.946 ([published Online First: Epub Date]|).
Kirchhof P, Camm AJ, Goette A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383(14):1305–16. https://doi.org/10.1056/nejmoa2019422 ([published Online First: Epub Date]|).
Saglietto A, De Ponti R, Di Biase L, et al. Impact of atrial fibrillation catheter ablation on mortality, stroke, and heart failure hospitalizations: a meta-analysis. J Cardiovasc Electrophysiol. 2020;31(5):1040–7. https://doi.org/10.1111/jce.14429 ([published Online First: Epub Date]|).
Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Ep Europace. 2018;20(1):e1–160.
January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1–76.
Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498.
Verma A, Jiang C-Y, Betts TR, et al. Approaches to Catheter Ablation for Persistent Atrial Fibrillation. N Engl J Med. 2015;372(19):1812–22. https://doi.org/10.1056/nejmoa1408288 ([published Online First: Epub Date]|).
Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). EP Europace. 2011;13(8):1077–109. https://doi.org/10.1093/europace/eur245 ([published Online First: Epub Date]|).
Schade A, Costello-Boerrigter L, Steinborn F, et al. Voltage-guided ablation in persistent atrial fibrillation—favorable 1-year outcome and predictors. J Interv Card Electrophysiol. 2021;62(2):249–57.
Rolf S, Hindricks G, Sommer P, et al. Electroanatomical mapping of atrial fibrillation: Review of the current techniques and advances. Rolf S, Hindricks G, Sommer P, Richter S, Arya A, Bollmann A, Kosiuk J, Koutalas E.J. Atr Fibrillation. 2014;7(4):1140. https://doi.org/10.4022/jafib.1140
Saini A, Huizar JF, Tan A, Koneru JN, Ellenbogen KA, Kaszala K. Scar homogenization in atrial fibrillation ablation: evolution and practice. Journal of Atrial Fibrillation 2017;10(3), https://doi.org/10.4022/jafib.1645 [published Online First: Epub Date]|.
Castrejón-Castrejón S, Ortega M, Pérez-Silva A, et al. Organized atrial tachycardias after atrial fibrillation ablation. Cardiol Res Pract. 2011;2011:1–16. https://doi.org/10.4061/2011/957538 ([published Online First: Epub Date]|).
Packer DL, Mark DB, Robb RA, et al. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation. JAMA. 2019;321(13):1261. https://doi.org/10.1001/jama.2019.0693 ([published Online First: Epub Date]|).
Kosiuk J, Hilbert S, John S, Bertagnolli L, Hindricks G, Bollmann A. Preliminary experience with high-density electroanatomical mapping for ablation of atrial fibrillation–Comparison of mini-basket and novel open irrigated magnetic ablation catheter in consecutive patients. Int J Cardiol. 2017;228:401–5.
Voskoboinik A, Moskovitch JT, Harel N, Sanders P, Kistler PM, Kalman JM. Revisiting pulmonary vein isolation alone for persistent atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm. 2017;14(5):661–7. https://doi.org/10.1016/j.hrthm.2017.01.003 ([published Online First: Epub Date]|).
Vogler J, Willems S, Sultan A, et al. Pulmonary vein isolation versus defragmentation: the CHASE-AF clinical trial. J Am Coll Cardiol. 2015;66(24):2743–52.
Wynn GJ, Panikker S, Morgan M, et al. Biatrial linear ablation in sustained nonpermanent AF: results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial. Heart Rhythm. 2016;13(2):399–406.
Khurram IM, Habibi M, GucukIpek E, et al. Left atrial LGE and arrhythmia recurrence following pulmonary vein isolation for paroxysmal and persistent AF. JACC: Cardiovascular Imaging. 2016;9(2):142–8.
Mark DB, Anstrom KJ, Sheng S, et al. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation. JAMA. 2019;321(13):1275. https://doi.org/10.1001/jama.2019.0692 ([published Online First: Epub Date]|).
Evans JM, Withers KL, Lencioni M, et al. Quality of life benefits from arrhythmia ablation: A longitudinal study using the C-CAP questionnaire and EQ5D. Pacing Clin Electrophysiol. 2019;42(6):705–11. https://doi.org/10.1111/pace.13675 ([published Online First: Epub Date]|).
留言 (0)